Doctor of Hope
How Professor Nagi El Saghir Changed the Language of Cancer in the Middle East and Helped Redefine Global Oncology The airport in Beirut looked very different in 1971. Families walked all the way to the aircraft. Parents accompanied their children…
Larry Leksell: The story of Elekta
“Tax planning was one major reason for the foundation of Elekta.” Larry Leksell says it with a smile that suggests he enjoys disrupting the mythology people create around founders. Most…
This is WHO
There is a lot being said about the World Health Organization these days. Criticism. Political tensions. Funding crises. Countries leaving. Endless speculation about what WHO is, what it failed to…
NEWS
Daraxonrasib: A Turning Point for Pancreatic Cancer
Pancreatic ductal adenocarcinoma remains one of the most difficult cancers to treat, with limited progress in drug development over the past decade. At the 2026 ASCO Annual Meeting, the Phase 3 RASolute 302 trial delivered results that stood out against…
CONTENTS
ARTICLES
Daraxonrasib: A Turning Point for Pancreatic Cancer
Pancreatic ductal adenocarcinoma remains one of the most difficult cancers to treat, with limited progress in drug development over the past decade. At the 2026 ASCO Annual Meeting, the Phase 3 RASolute 302 trial delivered results that stood out against…
